These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15149747

  • 1. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma.
    Lang H, Lindner V, Martin M, Letourneux H, Roy C, Saussine C, Jacqmin D.
    Eur Urol; 2004 Jun; 45(6):749-53. PubMed ID: 15149747
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up.
    Lang H, Lindner V, Letourneux H, Martin M, Saussine C, Jacqmin D.
    Eur Urol; 2004 Sep; 46(3):331-5. PubMed ID: 15306103
    [Abstract] [Full Text] [Related]

  • 3. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS, Lohse CM, Zincke H, Cheville JC, Blute ML.
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M.
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [Abstract] [Full Text] [Related]

  • 6. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW.
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
    Jeong IG, Jeong CW, Hong SK, Kwak C, Lee E, Lee SE.
    Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [Abstract] [Full Text] [Related]

  • 9. Prognostic relevance of capsular involvement and collecting system invasion in stage I and II renal cell carcinoma.
    Klatte T, Chung J, Leppert JT, Lam JS, Pantuck AJ, Figlin RA, Belldegrun AS.
    BJU Int; 2007 Apr; 99(4):821-4. PubMed ID: 17244281
    [Abstract] [Full Text] [Related]

  • 10. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M.
    Scand J Urol Nephrol; 2008 Apr; 42(6):507-13. PubMed ID: 19031267
    [Abstract] [Full Text] [Related]

  • 11. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y, Saito K, Sakai K, Morimoto S.
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
    May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S.
    Urol Oncol; 2010 Jan; 28(3):274-9. PubMed ID: 18805709
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality.
    Mejean A, Hopirtean V, Bazin JP, Larousserie F, Benoit H, Chrétien Y, Thiounn N, Dufour B.
    J Urol; 2003 Sep; 170(3):764-7. PubMed ID: 12913693
    [Abstract] [Full Text] [Related]

  • 14. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
    Amin MB, Paner GP, Alvarado-Cabrero I, Young AN, Stricker HJ, Lyles RH, Moch H.
    Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
    [Abstract] [Full Text] [Related]

  • 15. Prognostic value of the involvement of the urinary collecting system in renal cell carcinoma.
    Terrone C, Cracco C, Guercio S, Bollito E, Poggio M, Scoffone C, Tarabuzzi R, Porpiglia F, Scarpa RM, Fontana D, Rocca Rossetti S.
    Eur Urol; 2004 Oct; 46(4):472-6. PubMed ID: 15363563
    [Abstract] [Full Text] [Related]

  • 16. The Cleveland Clinic experience with papillary (chromophil) renal cell carcinoma: clinical outcome with histopathological correlation.
    Chow GK, Myles J, Novick AC.
    Can J Urol; 2001 Apr; 8(2):1223-8. PubMed ID: 11375785
    [Abstract] [Full Text] [Related]

  • 17. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J, Buse S, Pritsch M, Macher-Goeppinger S, Schirmacher P, Haferkamp A, Hohenfellner M.
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [Abstract] [Full Text] [Related]

  • 18. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE, Veys JA, Eskridge MR, Woodruff RD, Hall MC.
    Urol Oncol; 2005 Aug; 23(5):328-32. PubMed ID: 16144666
    [Abstract] [Full Text] [Related]

  • 20. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M.
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.